Genericon develops, manufactures and sells medicines containing proven, non-patented active substances of the latest generics. The wide and continually growing range of products includes the areas of rheumatics, cardiovascular system, metabolism, respiratory tract, depression, infections and blood circulation with approximately 200 forms of administration.
Since it was founded in 1986, Genericon has seen a rapid growth in the number of products. Together with the increasing requirements in pharmacovigilance it became obvious that a database solution was needed to classify, create, review, submit and maintain Pharmacovigilance data and adverse event reports. The solution Genericon was looking for had to be able to improve the efficiency in handling adverse events and to generate business critical reports for the company.
To read the full story register now and download the complete case study.